Gelonghui September 12 | Yangpu Healthcare (300030.SZ) was surveyed by investors on September 12, 2024. “What impact does the country's current liberalization of foreign medical investment and hospital investment have on your company? What are Gree's development proposals as the current majority shareholder?” The company said that currently the company's main product is a vacuum blood collection system, which does not involve foreign medical investment or hospital investment.
阳普医疗(300030.SZ)：目前主营产品为真空采血系统，不涉及外资医疗投资、医院投资
Improve Medical Instruments (300030.SZ): Currently, the main products are vacuum blood collection systems, not involving foreign medical investment or hospital investment
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated